Your session is about to expire
← Back to Search
Healthy Liver/Hígado Sano program for Non-alcoholic Fatty Liver Disease
N/A
Waitlist Available
Led By Natalia I Heredia, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months after enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a program that helps Hispanic/Latino patients with non-alcoholic fatty liver disease (NAFLD) adopt healthier eating and exercise habits to reduce liver fat and improve health.
Eligible Conditions
- Non-alcoholic Fatty Liver Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months after enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Intervention group participants Satisfaction of program as assessed by the Client Satisfaction Questionnaire (CSQ-8)
Secondary study objectives
Change in Anxiety as assessed by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire.
Change in Depression as assessed by the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
Change in Perceived treatment efficacy
+12 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Healthy Liver/Hígado Sano programExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthy Liver/Hígado Sano program
2022
N/A
~30
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
937 Previous Clinical Trials
337,404 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
91 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Prevent Cancer FoundationOTHER
6 Previous Clinical Trials
1,454 Total Patients Enrolled
Natalia I Heredia, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Share this study with friends
Copy Link
Messenger